DEPLOYDatabase

Company

Oura

Oura Health (Oura) is a Finnish health technology company developing the Oura Ring — a Smart ring wearable tracking sleep, heart rate, body temperature, and…

Founded
2013
HQ
Oulu, Finland
Status
private ($11B valuation; Series E ~$900M Oct 2025)

The verified answer

As of Aug 2026, DEPLOY verifies Oura: 1 model, 1 deployment across 1 region, $1.3B raised. 4 sources back the record.

CategoryBiometric wearables

Overview

Oura Health (Oura) is a Finnish health technology company developing the Oura Ring — a Smart ring wearable tracking sleep, heart rate, body temperature, and activity. Raised Series A through D funding. Over 2.5M rings sold. Founded in 2015, headquartered in Oulu, Finland.

Verified record

Verified deployments
1 deployment on file
Active incidents
None on file

Valuation of record

DEPLOY VERIFIED
$11B (reported, approximate)as of Dec 2025

Priced roundGrowth round (valuation reported) post-money

See the full valuations ranking →

Key facts

Founded

2013, Oulu, Finland

Founders

CEO

Tom Hale (2022-); previously Harpreet Rai (2018-2022)

Product

Oura Ring - titanium ring-form wearable tracking sleep, HRV, temperature, activity, readiness score

Customers

Consumer health, NBA, U.S. military, research institutions, women's health tracking

Patents

Patents on ring-form-factor sensor integration, temperature tracking, sleep staging algorithms

Units sold

2.5M+ rings

Data & sources

Press releases

1

News coverage

2

Web sources

1

4 sources backing this record.View all →

Current platform

Oura Ring 4

Oura (Oura Health, founded 2013 in Oulu, Finland) makes the Oura Ring, a biometric-primary titanium smart ring with sleep and readiness AI, recorded in the new biometric form factor, with the Oura Ring 4 from late 2024 introducing its Smart Sensing platform that expanded signal pathways from eight to eighteen on roughly an eight-day battery. It pairs heart-rate and heart-rate-variability, blood-oxygen-trend, multi-point temperature, and accelerometer sensing with sleep staging and a Sleep Score, a Readiness Score, activity, stress, cycle tracking with Natural Cycles integration, a VO2 Max estimate, and an AI Oura Advisor across more than 50 metrics, sold by purchase plus a required membership of $5.99 a month. On FDA status, the Oura Ring 4 itself has no clearance and is marketed as a general-wellness product, with its only cleared-feature route via partner integrations such as the FDA-cleared Natural Cycles birth-control app consuming Oura temperature data, where the clearance belongs to the partner. Oura is the disciplined counter-case to Whoop in the verified-versus-claimed framework: it launched a Blood Pressure Profile Study in December 2025 to pursue a hypertension feature, but that feature is investigational and not cleared, so Oura is running the clearance path before marketing blood pressure, in contrast to Whoop's market-first posture that drew an FDA warning letter. A valuation correction is worth recording: Oura is valued at $11 billion after a roughly $900 million Series E in October 2025 led by Fidelity with revenue reportedly above $1 billion in 2025, not the stale roughly $5 billion figure. Its clinical-validation posture is the strongest and growing in the cohort specifically on sleep, with a 2025 Brigham and Women's Hospital study finding it the most accurate consumer sleep tracker for four-stage classification against polysomnography, while its posture is validated wellness rather than a cleared medical device except via partners, and its blood-pressure feature and the accuracy of its Readiness and VO2 Max metrics are investigational or not clearance-validated.

biometricView model →

Oura on the deployment map

View the global map

1 verified deployment across 1 region, newest verified Jun 2024. Explore where Oura's robots are operating, by place and type.

Free to use on your site, with a link back to DEPLOY.

View the full Oura deployment record →

Free to use on your site, with a link back to DEPLOY.

Relationships

Explainers

Plain-language answers to the questions people ask about Oura, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

What is the FDA Warning Letter to Whoop about Blood Pressure Insights?
On July 14, 2025, the FDA issued a Warning Letter to Whoop finding that the company's marketing of Blood Pressure Insights (BPI), launched May 2025 for Whoop MG, positioned the feature beyond the general-wellness scope that does not require 510(k) clearance for diagnostic claims. Whoop refused to remove the feature, defended BPI as wellness, and faced a subsequent class action lawsuit; as of May 2026 the matter remains unresolved. Whoop's market-first posture vs Oura's December 2025 BP study before marketing is the biometric cohort's sharpest verified-vs-claimed exemplar pair.Read the full explainer →
What is Oura Ring 4?
Oura is a Finnish-founded biometric wearable company headquartered in Oulu and San Francisco; the Oura Ring 4 (current generation) is the cohort's study-first verification posture archetype. Where Whoop shipped Blood Pressure Insights in May 2025 without published clinical-validation study and drew an FDA Warning Letter, Oura ran a December 2025 BP study before any consumer BP feature shipped. Pricing: $349 outright + $5.99/month Oura Membership OR ~$400 lifetime membership. FDA posture: general-wellness only (no specific medical clearances); deepest peer-reviewed sleep validation in cohort. October 2025 funding round at $11B valuation positions Oura as Whoop's economic peer at opposite verification posture.Read the full explainer →

Current leadership (7)

Founders (3)

See all founders across the registry →

Board (3)

Former / Previously (2)

Safety record

No incidents on record for Oura.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Operator customers (1)

Recent coverage

Oura in third-party press

Peers

35 peers across 1 segment. Every Oura competitor derived from shared form-factor and application-domain edges.

wearable(35)

32 companies in this segment · highly_concentrated (HHI 2595.3892239124602) · leader Oculus VR at 4361%